Japanese
close

FI (list display)

  • C12Q1/00
    		•  Measuring or testing processes involving enzymes, nucleic acids or microorganisms (measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34); Compositions therefor; Processes of preparing such compositions [3] HB CC 4B063
  • C12Q1/00@B
    		•  Using enzyme electrodes HB CC 4B063
  • C12Q1/00@C
    		•  Fixed enzyme/microorganism specimen HB CC 4B063
  • C12Q1/00@Z
    		•  Others ( not a specific enzyme) HB CC 4B063
  • C12Q1/02
    		•  .involving viable micro-organisms [3] HB CC 4B063
  • C12Q1/04
    		•  ..Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor [3] HB CC 4B063
  • C12Q1/06
    		•  ...Quantitative determination [3] HB CC 4B063
  • C12Q1/08
    		•  ....using multifield media [3] HB CC 4B063
  • C12Q1/10
    		•  ...Enterobacteria [3] HB CC 4B063
  • C12Q1/12
    		•  ...Nitrate to nitrite reducing bacteria [3] HB CC 4B063
  • C12Q1/14
    		•  ...Streptococcus; Staphylococcus [3] HB CC 4B063
  • C12Q1/16
    		•  ...using radioactive material [3] HB CC 4B063
  • C12Q1/18
    		•  ..Testing for antimicrobial activity of a material [3] HB CC 4B063
  • C12Q1/20
    		•  ...using multifield media [3] HB CC 4B063
  • C12Q1/22
    		•  ..Testing for sterility conditions [3] HB CC 4B063
  • C12Q1/24
    		•  ..Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact micro-organism [3] HB CC 4B063
  • C12Q1/25
    		•  .involving enzymes not classifiable in groups C12Q 1/26-C12Q 1/70 [5] HB CC 4B063
  • C12Q1/26
    		•  .involving oxidoreductase [3] HB CC 4B063
  • C12Q1/28
    		•  ..involving peroxidase [3] HB CC 4B063
  • C12Q1/30
    		•  ..involving catalase [3] HB CC 4B063
  • C12Q1/32
    		•  ..involving dehydrogenase [3] HB CC 4B063
  • C12Q1/34
    		•  .involving hydrolase [3] HB CC 4B063
  • C12Q1/37
    		•  ..involving peptidase or proteinase [5] HB CC 4B063
  • C12Q1/40
    		•  ..involving amylase [3] HB CC 4B063
  • C12Q1/42
    		•  ..involving phosphatase [3] HB CC 4B063
  • C12Q1/44
    		•  ..involving esterase [3] HB CC 4B063
  • C12Q1/46
    		•  ...involving cholinesterase [3] HB CC 4B063
  • C12Q1/48
    		•  .involving transferase [3] HB CC 4B063
  • C12Q1/48@A
    		•  gGTP (g-glutamyl transferase) HB CC 4B063
  • C12Q1/48@Z
    		•  Others ( kinase, cf. mutase (enzymes displaced inside molecules) R 1/533) HB CC 4B063
  • C12Q1/50
    		•  ..involving creatine phosphokinase [3] HB CC 4B063
  • C12Q1/52
    		•  ..involving transaminase [3] HB CC 4B063
  • C12Q1/527
    		•  .involving lyase [5] HB CC 4B063
  • C12Q1/533
    		•  .involving isomerase [5] HB CC 4B063
  • C12Q1/54
    		•  .involving glucose or galactose [3] HB CC 4B063
  • C12Q1/56
    		•  .involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen [3] HB CC 4B063
  • C12Q1/58
    		•  .involving urea or urease [3] HB CC 4B063
  • C12Q1/60
    		•  .involving cholesterol [3] HB CC 4B063
  • C12Q1/61
    		•  .involving triglycerides [5] HB CC 4B063
  • C12Q1/62
    		•  .involving uric acid [3] HB CC 4B063
  • C12Q1/64
    		•  .Geomicrobiological testing, e.g. for petroleum [3] HB CC 4B063
  • C12Q1/66
    		•  .involving luciferase [3] HB CC 4B063
  • C12Q1/68
    		•  .involving nucleic acids [2018.01]
    		HB CC 4B063
  • C12Q1/68,100
    		•  ..Dummy fI C12Q1/68, dummy fI for setting up 100@C[stop new assigment] HB CC 4B063
  • C12Q1/68,100@C
    		•  for patent family with CPC C12Q1/68 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/68,100@Z
    		•  Others HB CC 4B063
  • C12Q1/6804
    		•  ..Nucleic acid analysis using immunogens (immunoassay G01N33/53) [2018.01] HB CC 4B063
  • C12Q1/6804@C
    		•  for patent family with CPC C12Q1/6804 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6804@Z
    		•  Others HB CC 4B063
  • C12Q1/6806
    		•  ..Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) [2018.01] HB CC 4B063
  • C12Q1/6806@C
    		•  for patent family with CPC C12Q1/6806 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6806@Z
    		•  Others HB CC 4B063
  • C12Q1/6809
    		•  ..Methods for determination or identification of nucleic acids involving differential detection [2018.01] HB CC 4B063
  • C12Q1/6809@C
    		•  for patent family with CPC C12Q1/6809 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6809@Z
    		•  Others HB CC 4B063
  • C12Q1/6811
    		•  ..Selection methods for production or design of target specific oligonucleotides or binding molecules [2018.01] HB CC 4B063
  • C12Q1/6811@C
    		•  for patent family with CPC C12Q1/6811 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6811@Z
    		•  Others HB CC 4B063
  • C12Q1/6813
    		•  ..Hybridisation assays [2018.01] HB CC 4B063
  • C12Q1/6813@C
    		•  for patent family with CPC C12Q1/6813 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6813@Z
    		•  Others HB CC 4B063
  • C12Q1/6816
    		•  ...characterised by the detection means (C12Q1/6804 takes precedence) [2018.01] HB CC 4B063
  • C12Q1/6816@C
    		•  for patent family with CPC C12Q1/6816 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6816@Z
    		•  Others HB CC 4B063
  • C12Q1/6818
    		•  ....involving interaction of two or more labels, e.g. resonant energy transfer [2018.01] HB CC 4B063
  • C12Q1/6818@C
    		•  for patent family with CPC C12Q1/6818 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6818@Z
    		•  Others HB CC 4B063
  • C12Q1/682
    		•  ....Signal amplification [2018.01] HB CC 4B063
  • C12Q1/682@C
    		•  for patent family with CPC C12Q1/682 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/682@Z
    		•  Others HB CC 4B063
  • C12Q1/6823
    		•  ....Release of bound markers [2018.01] HB CC 4B063
  • C12Q1/6823@C
    		•  for patent family with CPC C12Q1/6823 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6823@Z
    		•  Others HB CC 4B063
  • C12Q1/6825
    		•  ....Nucleic acid detection involving sensors [2018.01] HB CC 4B063
  • C12Q1/6825@C
    		•  for patent family with CPC C12Q1/6825 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6825@Z
    		•  Others HB CC 4B063
  • C12Q1/6827
    		•  ...for detection of mutation or polymorphism [2018.01] HB CC 4B063
  • C12Q1/6827@C
    		•  for patent family with CPC C12Q1/6827 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6827@Z
    		•  Others HB CC 4B063
  • C12Q1/683
    		•  ....involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP] [2018.01] HB CC 4B063
  • C12Q1/683@C
    		•  for patent family with CPC C12Q1/683 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/683@Z
    		•  Others HB CC 4B063
  • C12Q1/6832
    		•  ...Enhancement of hybridisation reaction [2018.01] HB CC 4B063
  • C12Q1/6832@C
    		•  for patent family with CPC C12Q1/6832 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6832@Z
    		•  Others HB CC 4B063
  • C12Q1/6834
    		•  ...Enzymatic or biochemical coupling of nucleic acids to a solid phase [2018.01] HB CC 4B063
  • C12Q1/6834@C
    		•  for patent family with CPC C12Q1/6834 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6834@Z
    		•  Others HB CC 4B063
  • C12Q1/6837
    		•  ....using probe arrays or probe chips (C12Q1/6874 takes precedence) [2018.01] HB CC 4B063
  • C12Q1/6837@C
    		•  for patent family with CPC C12Q1/6837 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6837@Z
    		•  Others HB CC 4B063
  • C12Q1/6839
    		•  ...Triple helix formation or other higher order conformations in hybridisation assays [2018.01] HB CC 4B063
  • C12Q1/6839@C
    		•  for patent family with CPC C12Q1/6839 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6839@Z
    		•  Others HB CC 4B063
  • C12Q1/6841
    		•  ...In situ hybridisation [2018.01] HB CC 4B063
  • C12Q1/6841@C
    		•  for patent family with CPC C12Q1/6841 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6841@Z
    		•  Others HB CC 4B063
  • C12Q1/6844
    		•  ..Nucleic acid amplification reactions [2018.01] HB CC 4B063
  • C12Q1/6844@C
    		•  for patent family with CPC C12Q1/6844 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6844@Z
    		•  Others HB CC 4B063
  • C12Q1/6848
    		•  ...characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction [2018.01] HB CC 4B063
  • C12Q1/6848@C
    		•  for patent family with CPC C12Q1/6848 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6848@Z
    		•  Others HB CC 4B063
  • C12Q1/6851
    		•  ...Quantitative amplification [2018.01] HB CC 4B063
  • C12Q1/6851@C
    		•  for patent family with CPC C12Q1/6851 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6851@Z
    		•  Others HB CC 4B063
  • C12Q1/6853
    		•  ...using modified primers or templates [2018.01] HB CC 4B063
  • C12Q1/6853@C
    		•  for patent family with CPC C12Q1/6853 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6853@Z
    		•  Others HB CC 4B063
  • C12Q1/6855
    		•  ....Ligating adaptors [2018.01] HB CC 4B063
  • C12Q1/6855@C
    		•  for patent family with CPC C12Q1/6855 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6855@Z
    		•  Others HB CC 4B063
  • C12Q1/6858
    		•  ...Allele-specific amplification [2018.01] HB CC 4B063
  • C12Q1/6858@C
    		•  for patent family with CPC C12Q1/6858 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6858@Z
    		•  Others HB CC 4B063
  • C12Q1/686
    		•  ...Polymerase chain reaction [PCR] [2018.01] HB CC 4B063
  • C12Q1/686@C
    		•  for patent family with CPC C12Q1/686 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/686@Z
    		•  Others HB CC 4B063
  • C12Q1/6862
    		•  ...Ligase chain reaction [LCR] [2018.01] HB CC 4B063
  • C12Q1/6862@C
    		•  for patent family with CPC C12Q1/6862 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6862@Z
    		•  Others HB CC 4B063
  • C12Q1/6865
    		•  ...Promoter-based amplification, e.g. nucleic acid sequence-based amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS] [2018.01] HB CC 4B063
  • C12Q1/6865@C
    		•  for patent family with CPC C12Q1/6865 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6865@Z
    		•  Others HB CC 4B063
  • C12Q1/6867
    		•  ...Replicase-based amplification, e.g. using Q-beta replicase [2018.01] HB CC 4B063
  • C12Q1/6867@C
    		•  for patent family with CPC C12Q1/6867 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6867@Z
    		•  Others HB CC 4B063
  • C12Q1/6869
    		•  ..Methods for sequencing [2018.01] HB CC 4B063
  • C12Q1/6869@C
    		•  for patent family with CPC C12Q1/6869 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6869@Z
    		•  Others HB CC 4B063
  • C12Q1/6872
    		•  ...involving mass spectrometry [2018.01] HB CC 4B063
  • C12Q1/6872@C
    		•  for patent family with CPC C12Q1/6872 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6872@Z
    		•  Others HB CC 4B063
  • C12Q1/6874
    		•  ...involving nucleic acid arrays, e.g. sequencing by hybridisation [SBH] [2018.01] HB CC 4B063
  • C12Q1/6874@C
    		•  for patent family with CPC C12Q1/6874 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6874@Z
    		•  Others HB CC 4B063
  • C12Q1/6876
    		•  ..Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes [2018.01] HB CC 4B063
  • C12Q1/6876@C
    		•  for patent family with CPC C12Q1/6876 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6876@Z
    		•  Others HB CC 4B063
  • C12Q1/6879
    		•  ...for sex determination [2018.01] HB CC 4B063
  • C12Q1/6879@C
    		•  for patent family with CPC C12Q1/6879 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6879@Z
    		•  Others HB CC 4B063
  • C12Q1/6881
    		•  ...for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes [2018.01] HB CC 4B063
  • C12Q1/6881@C
    		•  for patent family with CPC C12Q1/6881 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6881@Z
    		•  Others HB CC 4B063
  • C12Q1/6883
    		•  ...for diseases caused by alterations of genetic material [2018.01] HB CC 4B063
  • C12Q1/6883@C
    		•  for patent family with CPC C12Q1/6883 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6883@Z
    		•  Others HB CC 4B063
  • C12Q1/6886
    		•  ....for cancer (immunoassay for cancer G01N33/574) [2018.01] HB CC 4B063
  • C12Q1/6886@C
    		•  for patent family with CPC C12Q1/6886 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6886@Z
    		•  Others HB CC 4B063
  • C12Q1/6888
    		•  ...for detection or identification of organisms [2018.01] HB CC 4B063
  • C12Q1/6888@C
    		•  for patent family with CPC C12Q1/6888 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6888@Z
    		•  Others HB CC 4B063
  • C12Q1/689
    		•  ....for bacteria [2018.01] HB CC 4B063
  • C12Q1/689@C
    		•  for patent family with CPC C12Q1/689 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/689@Z
    		•  Others HB CC 4B063
  • C12Q1/6893
    		•  ....for protozoa [2018.01] HB CC 4B063
  • C12Q1/6893@C
    		•  for patent family with CPC C12Q1/6893 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6893@Z
    		•  Others HB CC 4B063
  • C12Q1/6895
    		•  ....for plants, fungi or algae [2018.01] HB CC 4B063
  • C12Q1/6895@C
    		•  for patent family with CPC C12Q1/6895 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6895@Z
    		•  Others HB CC 4B063
  • C12Q1/6897
    		•  ..involving reporter genes operably linked to promoters [2018.01] HB CC 4B063
  • C12Q1/6897@C
    		•  for patent family with CPC C12Q1/6897 is assigned [stop new assigment] HB CC 4B063
  • C12Q1/6897@Z
    		•  Others HB CC 4B063
  • C12Q1/70
    		•  .involving virus or bacteriophage [3] HB CC 4B063
    TOP